Drug Shortage Report for TEVA-ESOMEPRAZOLE
| Report ID | 114424 |
| Drug Identification Number | 02423855 |
| Brand name | TEVA-ESOMEPRAZOLE |
| Common or Proper name | ESOMEPRAZOLE 20MG OG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ESOMEPRAZOLE |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-05-06 |
| Estimated end date | 2020-12-31 |
| Actual end date | 2021-01-06 |
| Shortage status | Resolved |
| Updated date | 2021-01-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2021-01-07 | French | Compare |
| v11 | 2021-01-07 | English | Compare |
| v10 | 2020-12-03 | French | Compare |
| v9 | 2020-12-03 | English | Compare |
| v8 | 2020-10-01 | French | Compare |
| v7 | 2020-10-01 | English | Compare |
| v6 | 2020-09-03 | French | Compare |
| v5 | 2020-09-03 | English | Compare |
| v4 | 2020-07-30 | French | Compare |
| v3 | 2020-07-30 | English | Compare |
| v2 | 2020-05-08 | French | Compare |
| v1 | 2020-05-08 | English | Compare |
Showing 1 to 12 of 12